iifl-logo

Sandu Pharmaceuticals Ltd Board Meeting

50.07
(-0.16%)
Jul 2, 2025|12:00:00 AM

Sandu Pharma. CORPORATE ACTIONS

04/07/2024calendar-icon
04/07/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting28 May 202517 May 2025
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Audited Financial Results for Q and year ended 31.03.2025 and to approve Final Dividend if any for the FY ended 31.03.2025 Outcome of the Board Meeting (As Per BSE Announcement Dated on :28.05.2025)
Board Meeting13 Feb 20254 Feb 2025
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve 1.Approval of Standalone Unaudited Financial Results for Q ended 31st December 2024 2. any other matter with permission of chairman Appointment of the Internal Auditor for the FY 2025-26 (As Per BSE Announcement Dated on 13/02/2025)
Board Meeting14 Nov 20244 Nov 2024
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve approval of standalone and consolidated unaudited financials results for quarter and half year ended 30.09.2024 outcome of the Board Meeting dated 14th November 2024 (As Per BSE Announcement Dated on 14.11.2024) Corrigendum to the Outcome of the Board Meeting held on 14th November 2024 (As Per BSE Announcement Dated on 15.11.2024)
Board Meeting12 Aug 20243 Aug 2024
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve 1. To Approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter ended 30th June 2024. 2. To Consider and appoint Shri. Vijay Kottapalli (DIN: 10245156) as Additional Director (Non Executive Independent Director) of the Company. 3. To consider/recommend Dividend for the Financial Year 2023-24. Outcome of the Board Meeting dated 12th August 2024 (As Per BSE Announcement Dated on 12.08.2024)

Sandu Pharma.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.